Cargando…

Reduction in the Rate of Mortality of Moderate to Severe COVID 19 Infected Patients with the use of Remdesivir - A Tertiary Care Hospital-Based Retrospective Observational Study

BACKGROUND: As the waves of coronavirus disease 2019 (COVID-19) pandemic continues, the current treatment modalities emphasize the use of antiviral agents to save the human lives. Even though remdesivir is one of the current recommended modalities, data on the efficacy of remdesivir in reducing the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lakhanpal, Mahima, Sarkar, Debpriya, Kumar, Ritesh, Yadav, Isha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813984/ https://www.ncbi.nlm.nih.gov/pubmed/36620098 http://dx.doi.org/10.4103/aer.aer_55_22

Ejemplares similares

Intubation by using exaggerated curve: A modification of technique for underprivileged area
por: Ritesh, Kumar, et al.
Publicado: (2016)

Success rate of Remdesivir, Convalescent Plasma, and Tocilizumab in moderate to severe Covid-19 pneumonia: our experience in a tertiary care center
por: Mohanty, Bijaya, et al.
Publicado: (2021)

Use of canakinumab and remdesivir in moderate-severe COVID-19 patients: A retrospective analysis
por: Mastroianni, Antonio, et al.
Publicado: (2023)

Remdesivir treatment for patients with moderate to severe COVID-19
por: HASANOĞLU, İmran, et al.
Publicado: (2022)

Remdesivir in moderate to severe COVID-19: A matter of time?
por: Bonazzetti, Cecilia, et al.
Publicado: (2021)

Patients with moderate to severe COVID-19 outcomes on remdesivir according to baseline 4C mortality score
por: Sellers, Jacob, et al.
Publicado: (2023)

Remdesivir in pregnant women with moderate to severe coronavirus disease 2019 (COVID-19): a retrospective cohort study
por: Arbabzadeh, Taraneh, et al.
Publicado: (2023)

Remdesivir Treatment in Moderately Ill COVID-19 Patients: A Retrospective Single Center Study
por: Terkes, Vedrana, et al.
Publicado: (2022)

Estimating the effectiveness of remdesivir on risk of COVID-19 mortality: The role of observational data
por: Giacomelli, Andrea, et al.
Publicado: (2022)

A Retrospective Study of Dexamethasone, Remdesivir, and Baricitinib in Severe COVID-19
por: Ngo, Dallis Q., et al.
Publicado: (2022)

Remdesivir Treatment for COVID 19 in Pregnant Patients with Moderate to Severe Symptoms: Serial Case Report
por: Saroyo, Yudianto Budi, et al.
Publicado: (2021)

Effectiveness of remdesivir on hospital stay duration and mortality in patients with COVID-19 infection: A single-center retrospective observational study
por: Rai, Deependra Kumar
Publicado: (2022)

Adverse events following remdesivir administration in moderately ill COVID-19 patients - A retrospective analysis
por: Gandham, Ravi, et al.
Publicado: (2022)

Clinical outcomes of using remdesivir in patients with moderate to severe COVID-19: A prospective randomised study
por: Mahajan, Lakshmi, et al.
Publicado: (2021)

Remdesivir and Mortality in Patients With Coronavirus Disease 2019
por: Diaz, George A, et al.
Publicado: (2021)

A shorter symptom onset to remdesivir treatment (SORT) interval is associated with a lower mortality in moderate-to-severe COVID-19: A real-world analysis
por: Mehta, Ravindra M., et al.
Publicado: (2021)

72. Remdesivir vs Standard Care in Patients with Moderate covid-19
por: Marty, Francisco M, et al.
Publicado: (2020)

Evaluation of Remdesivir for Mildly to Moderately Ill Patients with COVID-19: A Single-Arm, Single-Center, Retrospective Study
por: Miyazaki, Motoyasu, et al.
Publicado: (2022)

Therapeutic Efficacy and Outcomes of Remdesivir versus Remdesivir with Tocilizumab in Severe SARS-CoV-2 Infection
por: Vulturar, Damiana-Maria, et al.
Publicado: (2022)

Safety and Efficacy of Combination Therapy of Remdesivir, Baricitinib, and High-dose Steroids in Patients Hospitalized with Moderate to Severe COVID-19
por: Nagasawa, Ryo, et al.
Publicado: (2023)

Remdesivir
por: Bakheit, Ahmed H., et al.
Publicado: (2023)

The safety, tolerability and mortality reduction efficacy of remdesivir; based on randomized clinical trials, observational and case studies reported safety outcomes: an updated systematic review and meta-analysis
por: Santenna, Chenchula, et al.
Publicado: (2021)

561. Safety of Remdesivir vs Standard Care in Patients with Moderate Covid-19
por: Criner, Gerard J, et al.
Publicado: (2020)

Remdesivir Versus Standard-of-Care for Severe Coronavirus Disease 2019 Infection: An Analysis of 28-Day Mortality
por: Olender, Susan A, et al.
Publicado: (2021)

Is there a weekend effect on mortality rate and outcome for moderate and severe traumatic brain injury? A population-based, observational cohort study
por: Andreassen, Joakim Stray, et al.
Publicado: (2022)

Population pharmacokinetics and exposure–clinical outcome relationship of remdesivir major metabolite GS‐441524 in patients with moderate and severe COVID‐19
por: Tamura, Ryo, et al.
Publicado: (2023)

Compassionate Use of Remdesivir for Patients with Severe Covid-19
por: Grein, Jonathan, et al.
Publicado: (2020)

Remdesivir cost effective for severe COVID-19 in China
Publicado: (2021)

Length of remdesivir treatment in patients with severe COVID-19
por: Ippolito, Mariachiara, et al.
Publicado: (2021)

Is It Time to Revisit Remdesivir Use for Severe COVID-19?
por: Taggarsi, Dipali Anand
Publicado: (2022)

Remdesivir Reduces Mortality in Hemato-Oncology Patients with COVID-19
por: Aksak-Wąs, Bogusz Jan, et al.
Publicado: (2022)

Remdesivir Decreases Mortality in COVID-19 Patients with Active Malignancy
por: Jaroszewicz, Jerzy, et al.
Publicado: (2022)

Scattered Musculoskeletal Venous Malformations in Children: A Rare Report on Clinical Evaluation and Sclerotherapy with Adjunctive Stasis of Efflux
por: Palo, Nishit, et al.
Publicado: (2023)

Mortality rate reduction associated with a severe sepsis management protocol implementation
por: de Sousa, AG, et al.
Publicado: (2007)

Early Use of Remdesivir in Patients Hospitalized With COVID-19 Improves Clinical Outcomes: A Retrospective Observational Study
por: Paranjape, Neha, et al.
Publicado: (2021)

Real-World Experience of the Comparative Effectiveness and Safety of Combination Therapy with Remdesivir and Monoclonal Antibodies versus Remdesivir Alone for Patients with Mild-to-Moderate COVID-19 and Immunosuppression: A Retrospective Single-Center Study in Aichi, Japan
por: Hirai, Jun, et al.
Publicado: (2023)

474. Real-World Experience of the Comparative Effectiveness and Safety of Remdesivir and Combination Therapy (Remdesivir and Monoclonal Antibodies) in Immunosuppressed Patients with Mild to Moderate COVID-19: A Retrospective Single-center Study in a Community Setting
por: Hirai, Jun, et al.
Publicado: (2023)

Clinicopathological features of hemophilia in a tertiary care centre of India
por: Pawan, Pandey K., et al.
Publicado: (2021)

Retinal OCT findings in acute central retinal artery occlusion of varying severity at different disease stages – a retrospective, observational study
por: Mangla, Rubble, et al.
Publicado: (2023)

Remdesivir in Breastfeeding
por: Sadati, Elham, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s25d8mnfin54aonsgkeaebo7rl